Clinical Trial Update: Study on Risk Factors and Prognosis of MASLD

View source ↗

Summary

A completed clinical trial investigating risk factors and prognosis for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Status: COMPLETED